PUBLISHER: The Business Research Company | PRODUCT CODE: 2098813
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098813
Intraoperative fluorescence imaging is an advanced real-time surgical imaging technique that employs fluorescent agents and specialized imaging equipment to visualize internal anatomical structures, including blood vessels, tissues, and tumors, during surgical procedures. It improves the surgeon's ability to differentiate between healthy and diseased tissues, evaluate tissue perfusion, and increase procedural precision in areas such as oncology and reconstructive surgery, thereby contributing to safer operations and more accurate clinical outcomes.
The primary components of intraoperative fluorescence imaging consist of products and services. Products refer to specialized imaging systems and agents used during surgical procedures to enable real-time visualization of tissues, blood flow, and tumor margins. These technologies operate on modalities including near-infrared fluorescence imaging, visible light fluorescence imaging, targeted fluorescence imaging, and non-targeted fluorescence imaging, and are used across system types such as open surgical imaging systems, minimally invasive or laparoscopic imaging systems, and robot-assisted imaging systems. The various applications include oncology surgery, cardiovascular surgery, neurosurgery, reconstructive surgery, gastrointestinal surgery, urology surgery, and post-stroke rehabilitation procedures, and they are utilized by end users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutes.
Tariffs are influencing the intraoperative fluorescence imaging market by elevating the prices of imported surgical imaging systems, specialized camera units, optical sensing components, and fluorescent contrast agents utilized in advanced operative procedures. This is driving up procurement expenditures for hospitals and surgical centers, especially in import-dependent regions such as Asia-Pacific and Latin America, where adoption of advanced surgical imaging technologies is still in an expansion phase. Hardware-intensive segments such as imaging systems and detector modules are the most impacted due to their dependence on global semiconductor supply chains and precision optics manufacturing networks. However, tariffs are also stimulating domestic manufacturing of imaging devices, boosting regional R&D efforts in contrast agent development, and promoting diversification of supplier ecosystems, which could strengthen long-term technological self-reliance.
The intraoperative fluorescence imaging market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to limited availability of real-time surgical visualization technologies, elevated rates of intraoperative complications, growing adoption of minimally invasive surgical procedures, early implementation of dye-based angiography methods, and increasing demand for precision-driven oncology surgeries.
The intraoperative fluorescence imaging market size is expected to see rapid growth in the next few years. It will grow to $1.31 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to expansion of AI-powered surgical imaging systems, rising demand for precision-based and personalized surgical procedures, increasing adoption of robotic-assisted surgeries, advancements in fluorescence contrast agent technologies, and growing integration of real-time imaging in hybrid operating rooms. Key trends include AI-assisted interpretation of surgical fluorescence signals, real-time image-guided intraoperative surgical techniques, improved accuracy in tumor margin detection, integration of robotic systems with fluorescence-guided procedures, and development of next-generation near-infrared imaging contrast agents.
The growing preference for minimally invasive procedures is expected to drive the growth of the intraoperative fluorescence imaging market going forward. Minimally invasive procedures are medical techniques that utilize small incisions or natural body openings along with specialized instruments to reduce tissue damage, pain, and recovery time compared to open surgical procedures. Minimally invasive procedures are increasing primarily because they enable faster patient recovery with reduced pain and shorter hospital stays due to minimized tissue damage. Intraoperative fluorescence imaging supports minimally invasive procedures by offering real-time visualization of blood flow, tissue perfusion, and critical anatomical structures using fluorescent dyes, enabling surgeons to operate through small incisions with enhanced precision, reduced risk of injury, and improved surgical outcomes. For instance, in March 2023, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries were performed in 2022 in the UK, marking a significant 102% increase compared to the previous year. Therefore, the growing preference for minimally invasive procedures is driving the growth of the intraoperative fluorescence imaging market.
Leading companies operating in the intraoperative fluorescence imaging market are focusing on developing innovative solutions such as the near-infrared (NIR) fluorescence imaging module to enhance real-time tissue visualization, improve surgical precision, and support better intraoperative decision-making. A near-infrared (NIR) fluorescence imaging module is a surgical imaging technology that uses near-infrared light and fluorescent dyes to provide real-time visualization of tissues and blood flow during surgery. for example, in March 2024, Synaptive Medical Inc., a Canada-based medical device company, received FDA 510(k) clearance for Modus IR, its near-infrared fluorescence module integrated with the Modus X robotic exoscope. The solution enables surgeons to visualize indocyanine green fluorescence and blood vessels in real time during microsurgical procedures, enhancing intraoperative imaging and surgical precision.
In November 2025, FluoGuide A/S, a Denmark-based clinical-stage biotechnology company, entered into a partnership with Carl Zeiss AG to co-develop FG001 for tumor imaging and surgical margin evaluation in head and neck cancer procedures. Through this collaboration, both companies aim to integrate FG001 with ZEISS surgical imaging platforms to enhance real-time tumor visualization and improve surgical margin assessment during cancer surgeries. Carl Zeiss AG is a Germany-based technology company providing intraoperative fluorescence imaging solutions.
Major companies operating in the intraoperative fluorescence imaging market are Medtronic plc, Stryker Corporation, Intuitive Surgical Inc., Olympus Corporation, Carl Zeiss Meditec AG, KARL STORZ SE & Co. KG, Shimadzu Corporation, Hamamatsu Photonics K.K., Leica Microsystems, Richard Wolf GmbH, SCHOLLY FIBEROPTIC GMBH, Guerbet, Diagnostic Green GmbH, LI-COR Biosciences, Activ Surgical Inc., OnLume Inc., Curadel Pharma Inc., SurgiMab SAS, FluoGuide
North America was the dominant region in the intraoperative fluorescence imaging market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in intraoperative fluorescence imaging report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intraoperative fluorescence imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intraoperative fluorescence imaging market consists of revenues earned by entities by providing services such as tissue perfusion assessment, tumor margin visualization, and sentinel lymph node mapping. The market value includes the value of related goods sold by the service provider or included within the service offering. The intraoperative fluorescence imaging market also includes sales of fluorescence-guided surgery systems, intraoperative imaging cameras, real-time surgical navigation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The intraoperative fluorescence imaging market research report is one of a series of new reports from The Business Research Company that provides intraoperative fluorescence imaging market statistics, including intraoperative fluorescence imaging industry global market size, regional shares, competitors with a intraoperative fluorescence imaging market share, detailed intraoperative fluorescence imaging market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative fluorescence imaging industry. This intraoperative fluorescence imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intraoperative Fluorescence Imaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intraoperative fluorescence imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intraoperative fluorescence imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intraoperative fluorescence imaging market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.